What is the level of liabilities of Veracyte this year?
Veracyte has a debt balance of 70.8 M USD this year.
Veracyte Liabilities 2024
Veracyte Liabilities
70.8 M USD
Veracyte Dividend yield
Ticker
VCYT
ISIN
US92337F1075
WKN
A1W7EA
In 2024, Veracyte's total liabilities amounted to 70.8 M USD, a -12.8% difference from the 81.2 M USD total liabilities in the previous year.
Veracyte Aktienanalyse
What does Veracyte do?
Veracyte Inc is a company that specializes in the development and marketing of diagnostic tests for a wide range of diseases and disorders. The company was founded in 2008 and is headquartered in South San Francisco, California. The history of Veracyte Inc begins with the vision to help patients with better diagnostic options. The company has used its expertise in gene expression technology to develop tests that facilitate the diagnosis of diseases and disorders in various areas, such as cancer, thyroid diseases, and lung diseases. Veracyte Inc's business model is based on selling diagnostic tests to healthcare facilities, hospitals, doctors, and other medical institutions. The tests are performed by specially trained professionals and can provide a precise diagnosis that helps doctors plan individualized treatment. Veracyte Inc is divided into different divisions to offer the best and most precise test for each area. The divisions include cancer diagnosis, thyroid diagnostics, lung diagnostics, and other areas of gene expression technology. In cancer diagnosis, Veracyte Inc offers tests for various types of cancer, such as breast cancer, thyroid cancer, and lung cancer. The tests use RNA sequencing to analyze the patient's genetic information and provide a more precise diagnosis. In thyroid diagnostics, Veracyte Inc offers tests for various thyroid diseases that are often difficult to diagnose. The tests help avoid unnecessary surgeries or medical interventions and enable patients to receive a more accurate diagnosis and treatment. In lung diagnostics, Veracyte Inc offers tests for pneumonia, lung cancer, and other lung diseases. The tests use RNA sequencing and imaging to provide accurate diagnoses that help doctors recommend tailored treatment. In addition to these divisions, Veracyte Inc also offers other products and services, such as information campaigns and training for healthcare professionals, as well as support and counseling for patients and their families. Overall, Veracyte Inc aims to revolutionize the medical field and provide patients with better diagnosis and treatment options. The company's tests offer doctors and patients a more precise and personalized diagnosis, allowing for individualized treatment and achieving the best results. Veracyte ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing Veracyte's Liabilities
Veracyte's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Veracyte's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing Veracyte's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
Veracyte's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in Veracyte’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about Veracyte Stock
What were the liabilities of Veracyte compared to the previous year?
The liabilities of Veracyte have increased by -12.8% dropped compared to the previous year.
What are the consequences of high debt for investors of Veracyte?
High liabilities can pose a risk for investors of Veracyte, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in Veracyte?
Low liabilities mean that Veracyte has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of Veracyte affect the company?
An increase in liabilities of Veracyte can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of Veracyte affect the company?
A decrease in the liabilities of Veracyte can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of Veracyte?
Some factors that can influence the liabilities of Veracyte include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of Veracyte so important for investors?
The liabilities of Veracyte are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can Veracyte take to modify the liabilities?
To change its liabilities, Veracyte can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does Veracyte pay?
Over the past 12 months, Veracyte paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Veracyte is expected to pay a dividend of 0 USD.
What is the dividend yield of Veracyte?
The current dividend yield of Veracyte is .
When does Veracyte pay dividends?
Veracyte pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Veracyte?
Veracyte paid dividends every year for the past 0 years.
What is the dividend of Veracyte?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Veracyte located?
Veracyte is assigned to the 'Health' sector.
Wann musste ich die Aktien von Veracyte kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Veracyte from 5/26/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/26/2024.
When did Veracyte pay the last dividend?
The last dividend was paid out on 5/26/2024.
What was the dividend of Veracyte in the year 2023?
In the year 2023, Veracyte distributed 0 USD as dividends.
In which currency does Veracyte pay out the dividend?
The dividends of Veracyte are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Veracyte stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Veracyte
Our stock analysis for Veracyte Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Veracyte Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
